FIGURE 3.
The mechanism-based medicines such as epigenetic drugs and inhibitors of signaling pathways could reprogram the fate of HTLV-1-infected cells (conceptualized as a reduction or elevation of the walls (blue arrows), which promote crossing or bypassing within the epigenetic landscape (black curved arrows) into the normal state).